Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.
Genespire has raised $52.2M in total funding. The most recent round was Series B. The last funding was announced in September 2024.
Genespire's investors include CDP Venture Capital, Sofinnova Partners, Indaco Venture Partners, XGEN Venture.
Genespire is headquartered in Milan, Italy.
Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.
Genespire is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Genespire — Funding & Investors." VCBacked, September 24, 2024, https://www.vcbacked.co/company/genespire. Accessed July 19, 2026.
VCBacked. (2024). Genespire — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/genespire
{{cite web |title=Genespire — Funding & Investors |url=https://www.vcbacked.co/company/genespire |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated